Close Menu

NEW YORK (GenomeWeb) – Danaher's proposed $4 billion acquisition of Cepheid has cleared antitrust requirements, Cepheid announced today.

Specifically, the firm said antitrust clearances have been received or the required waiting periods have expired in the US, Germany, Austria, and South Africa. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.